3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
7
Terminated
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Colonic Neoplasms
3
Breast Neoplasms
3
Rectal Neoplasms
2
Leukemia, Myeloid, Acute
2
Colorectal Neoplasms
2
Vitamin D Deficiency
1
Renal Insufficiency, Chronic
1
Pulmonary Disease, Chronic Obstructive
1
Prostatic Neoplasms
1
Precancerous Conditions
1
Osteoporosis
1
Obesity
1
Neurofibromatosis 1
1
Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Musculoskeletal Diseases
1
Melanoma
1
Locally Advanced Breast Cancer and Large Operable Breast Cancer
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Leukemia, B-Cell
1
Leukemia
1
Healthy, no Evidence of Disease
1
Congenital Abnormalities
1
Cardiovascular Diseases
1
Interventions
Gemcitabine
34
pembrolizumab
26
Paclitaxel
21
Cyclophosphamide
21
Docetaxel
20
Carboplatin
20
Irinotecan
19
Capecitabine
19
Fluorouracil
17
Bevacizumab
15
Dexamethasone
14
fludarabine
13
Oxaliplatin
13
Leucovorin
13
Blood Specimen Collection
13
Everolimus
12
Cetuximab
12
Ipilimumab
11
Erlotinib Hydrochloride
11
Rituximab
10
Pemetrexed
10
Cisplatin
10
venetoclax
9
Temozolomide
9
Sunitinib
9
Nivolumab
9
Trastuzumab
8
Interleukin-2
8
aldesleukin
7
Epoetin Alfa
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Neoplasms
×
Cholecalciferol
×
Clear all
NCT01817699
2019-02-04
CANDLE-KIT
CANDLE-KIT Trial Study Group
Phase 4
Terminated
161 enrolled